Inhibition of DNA topoisomerase I activity by 2',5'-oligoadenylates and mismatched double-stranded RNA in uninfected and HIV-1-infected H9 cells.

[1]  U. Scheffer,et al.  Mode of action of the anti-AIDS compound poly(I).poly(C12U) (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase. , 1993, Journal of interferon research.

[2]  H. Schröder,et al.  (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection. , 1992, The International journal of biochemistry.

[3]  K. Karikó,et al.  Heterogeneous nuclear RNA from hairy cell leukemia patients activates 2',5'-oligoadenylate synthetase. , 1991, Anticancer research.

[4]  P. Torrence,et al.  2',5'-oligoadenylates inhibit relaxation of supercoiled DNA by calf thymus DNA topoisomerase I. , 1991, Journal of interferon research.

[5]  L. Leserman,et al.  Cordycepin analogues of 2',5'-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase. , 1991, Biochemistry.

[6]  D. Blair,et al.  Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor. , 1991, AIDS research and human retroviruses.

[7]  S. Segal,et al.  Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. , 1990, The EMBO journal.

[8]  Werner Müller,et al.  Differential in vitro Anti-HIV Activity of Natural Lignans , 1990, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[9]  T. Okamoto,et al.  Binding of Tat protein to TAR region of human immunodeficiency virus type 1 blocks TAR-mediated activation of (2'-5')oligoadenylate synthetase. , 1990, AIDS research and human retroviruses.

[10]  J. Moskow,et al.  8-Azido double-stranded RNA photoaffinity probes. Enzymatic synthesis, characterization, and biological properties of poly(I,8-azidoI).poly(C) and poly(I,8-azidoI).poly(C12U) with 2',5'-oligoadenylate synthetase and protein kinase. , 1990, The Journal of biological chemistry.

[11]  T. Okamoto,et al.  Functional characterization of Tat protein from human immunodeficiency virus. Evidence that Tat links viral RNAs to nuclear matrix. , 1990, The Journal of biological chemistry.

[12]  W. Müller,et al.  Age-dependent increase of DNA topoisomerase II activity in quail oviduct; modulation of the nuclear matrix-associated enzyme activity by protein phosphorylation and poly(ADP-ribosyl)ation. , 1989, Mutation research.

[13]  D. Montefiori,et al.  Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. Kuchino,et al.  Modulation of nuclear matrix-associated 2',5'-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. , 1989, The Journal of biological chemistry.

[15]  N. Osheroff,et al.  Phosphorylation of DNA topoisomerase II in vivo and in total homogenates of Drosophila Kc cells. The role of casein kinase II. , 1988, The Journal of biological chemistry.

[16]  R. Silverman,et al.  Purification and analysis of murine 2-5A-dependent RNase. , 1988, The Journal of biological chemistry.

[17]  R. Cohrs,et al.  Occurrence of 2-5A and RNA degradation in the chick oviduct during rapid estrogen withdrawal. , 1988, Biochemistry.

[18]  S. Chamaret,et al.  Characterization of 69- and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells. , 1988, The Journal of biological chemistry.

[19]  W. Müller,et al.  Alteration of nuclear (2'-5')oligoriboadenylate synthetase and nuclease activities preceding replication of human immunodeficiency virus in H9 cells. , 1988, Biological chemistry Hoppe-Seyler.

[20]  Werner Müller,et al.  Specific phosphorylation of proteins in pore complex‐laminae from the sponge Geodia cydonium by the homologous aggregation factor and phorbol ester. Role of protein kinase C in the phosphorylation of DNA topoisomerase II. , 1987, The EMBO journal.

[21]  B. Moss,et al.  Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Montefiori,et al.  CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL EFFECTS OF AMPLIGEN, A MISMATCHED DOUBLE-STRANDED RNA, IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX , 1987, The Lancet.

[23]  D. Montefiori,et al.  Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K C Zoon,et al.  Interferons and their actions. , 1987, Annual review of biochemistry.

[25]  D. Strayer,et al.  Antiproliferative effect of mismatched double-stranded RNA on fresh human tumor cells analyzed in a clonogenic assay. , 1986, Journal of interferon research.

[26]  W. G. Kelly,et al.  ATP inhibits nuclear and mitochondrial type I topoisomerases from human leukemia cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[27]  N. Osheroff,et al.  In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Vosberg,et al.  Characterisation of size variants of type I DNA topoisomerase isolated from calf thymus. , 1984, European journal of biochemistry.

[29]  C. Bisbal,et al.  Increased stability and antiviral activity of 2'-O-phosphoglyceryl derivatives of (2'-5')oligo(adenylate). , 1984, European journal of biochemistry.

[30]  H. Cailla,et al.  Immunological evidence for the in vivo occurrence of (2'-5')adenylyladenosine oligonucleotides in eukaryotes and prokaryotes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Muller,et al.  Rapid detection and isolation of covalent DNA/protein complexes: application to topoisomerase I and II. , 1984, The EMBO journal.

[32]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[33]  N. Osheroff,et al.  DNA topoisomerase II from Drosophila melanogaster. Relaxation of supercoiled DNA. , 1983, The Journal of biological chemistry.

[34]  J. Dumont,et al.  (2'-5')Oligoadenylate in rat liver: modulation after partial hepatectomy. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Wu,et al.  Enzymatic synthesis of the 2',5'-A4 tetramer analog, 2',5'-ppp3'dA(p3'dA)3, by rabbit reticulocyte lysates: binding and activation of the 2',5'-A eta dependent nuclease, hydrolysis of mRNA, and inhibition of protein synthesis. , 1983, Biochemical and biophysical research communications.

[36]  P. Lengyel,et al.  Interferon action. Covalent linkage of (2'-5')pppApApA(32P)pCp to (2'-5')(A)n-dependent ribonucleases in cell extracts by ultraviolet irradiation. , 1982, The Journal of biological chemistry.

[37]  T. Nilsen,et al.  Presence of 2',5'-oligo(A) and of enzymes that synthesize, bind, and degrade 2',5'-oligo(A) in HeLa cell nuclei. , 1982, The Journal of biological chemistry.

[38]  I. Kerr,et al.  Synthesis, characterization and properties of ppp(A2'p)nApCp and related high-specific-activity 32P-labelled derivatives of ppp(A2'p)nA. , 2005, European journal of biochemistry.

[39]  J. Mosca,et al.  Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Faras,et al.  DNA topoisomerase activity associated with Rous sarcoma virus. , 1981, Virology.

[41]  C. Baglioni,et al.  Interferon action may be mediated by activation of a nuclease by pppA2′p5′A2′p5′A , 1978, Nature.

[42]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.